drugset / Trial / NCT00838682

Effect of High-dose Oral Rabeprazole on Recurrent Bleeding After the Endoscopic Treatment of Bleeding Peptic Ulcers

NCT00838682

RandomizedParallel-groupOpen-labelTreatment

Summary

This study is conducted to compare and evaluate the effect of administering a high-dose intravenous proton pump inhibitors or high-dose oral Rabeprazole in preventing recurrent bleeding after the endoscopic treatment of bleeding peptic ulcers.

Timeline

Start
2006-04
Primary completion
2009-01
Completion
2009-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Omeprazole Other / unclassified 8 mg Intravenous
Subject Rabeprazole Small molecule 10 mg Oral

Indications